# Novel optical measurement technique for antimicrobial photodynamic therapy using Scattered Light Integrating Collector (SLIC)

**Authors:** Marianna Leite de Avellar, Hassan Hafeez, Robert Hammond, Ifor D. W. Samuel

PMC · DOI: 10.1038/s41598-025-34122-z · 2026-01-14

## TL;DR

A new optical technique called SLIC is introduced to rapidly evaluate antimicrobial photodynamic therapy using real-time bacterial growth measurements.

## Contribution

The Scattered Light Integrating Collector (SLIC) is presented as a novel optical tool for real-time screening of antimicrobial photodynamic therapy.

## Key findings

- SLIC enables rapid screening of different photosensitizer concentrations during aPDT.
- Using methylene blue and OLEDs, significant inhibition of Staphylococcus aureus growth was observed.
- The technique allows real-time observation of aPDT effects on bacterial cultures.

## Abstract

Advancing new treatment modalities for microbial infections is a priority, given the threat of antimicrobial resistance. Current work includes the development of new non-traditional treatments, including antimicrobial photodynamic therapy (aPDT). Improvements in the field include innovative technologies that allow screening and optimization of the treatment. In this work it is shown how the Scattered Light Integrating Collector, a novel technology that optically measures bacterial growth in real time, can be used for rapid screening of aPDT using Organic Light Emitting Diodes (OLEDs) as the light source. This technology allows rapid screening of different concentrations of the photosensitizer and real-time observation of the effect of aPDT on Staphylococcus aureus. Evaluation of aPDT efficacy using methylene blue and OLEDs as the light source showed significant inhibition of the growth of S. aureus (3.06, 3.80, 4.24, 4.98 and 4.84 log10 reduction for the concentrations of MB of 1, 2, 4, 8 and 16 µM, respectively). The application of SLIC as a novel technology for evaluation of aPDT is a promising advance that will allow rapid optimization of the treatment.

The online version contains supplementary material available at 10.1038/s41598-025-34122-z.

## Linked entities

- **Chemicals:** methylene blue (PubChem CID 4139)
- **Species:** Staphylococcus aureus (taxon 1280)

## Full-text entities

- **Diseases:** microbial infections (MESH:D015163), toxicity (MESH:D064420), infections (MESH:D007239), bacterial (MESH:D001424), infected diabetic foot ulcers (MESH:D017719), fungal (MESH:D009181), aPDT (MESH:D016609), cutaneous leishmaniasis (MESH:D016773)
- **Chemicals:** (2-methyldibenzo[f,h]quinoxaline)(acetylacetonate) iridium(III) (-), isopropanol (MESH:D019840), nitrogen (MESH:D009584), Cesium (MESH:D002586), Ag (MESH:D012834), Al (MESH:D000535), MB (MESH:D008751), acetone (MESH:D000096), 4,7-diphenyl-1,10-phenanthroline (MESH:C006686), glycerol (MESH:D005990), oxygen (MESH:D010100), ROS (MESH:D017382)
- **Species:** Candida [taxon 1535326], Staphylococcus aureus (species) [taxon 1280], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12855195/full.md

---
Source: https://tomesphere.com/paper/PMC12855195